1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cholangiocarcinoma Advanced: new trials by email Literature Review of Cholangiocarcinoma Advanced trials Research Report on Cholangiocarcinoma Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CT-95 in Advanced Cancers Associated With Mesothelin Expression CT-95 - Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer | Phase 1 | Terminated | Context Therapeutics Inc. | 19 | 2025-03-31 | 2026-11-05 |
| Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies nal-IRI, 5-FU, leucovorin - Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic | Phase 2 | Completed | AIO-Studien-gGmbH | 100 | 2017-10-24 | 2022-05-18 |
Carcinoma, Ovarian Epithelial (1) · Colorectal Neoplasms (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Adenoma (1) · Adnexal Diseases (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1)
Fluorouracil (1) · Leucovorin (1) · irinotecan sucrosofate (1)
AIO-Studien-gGmbH (1) · Context Therapeutics Inc. (1)
Germany (1) · United States (1)
Arndt Vogel, Prof. (1) · Karen Chagin, MD (1)
2016 (1)